Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-003835

Chief Financial Officer sold 50,000 shares at an average $63.41 ($3,170,268)

  • Chief Financial Officer acquired 50,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Cohen Chad M · Chief Financial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-13 Exercise or conversion : show line 1 in the form +50,000 $6.32 $316,000 51,000 D
2021-01-13 Sale : show line 2 in the form −15,820 $62.92 $995,394 35,180 D
2021-01-13 Sale : show line 3 in the form −34,180 $63.63 $2,174,873 1,000 D
Open-market sales · 50,000 sh · avg $63.41 · $3,170,268

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-01-13 Exercise or conversion : show line 4 in the form Stock Option (Right To Buy) −50,000 365,000 D
Loading xslF345X03/doc4.xml…